| ²é¿´: 2927 | »Ø¸´: 10 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
jianxiao88ľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¹ØÓÚÅ·ÖÞÒ©µäµÄ·½·¨ÖÐÔÓÖÊ¿ØÖƵÄÒÉ»ó ÒÑÓÐ2È˲ÎÓë
|
||
| ¹ØÓÚÅ·ÖÞÒ©µäÖлÆÌåͪµÄ·½·¨£¬ÕýÎĹ涨µ¥ÔÓ²»´óÓÚ0.5%£¬¶ÔÓÚÌØÊâÔÓÖÊûÓÐÌØÊâÒªÇ󣬵«ÊÇÕýÎĵÄ×îºóÁгöµÄÖÚ¶àÔÓÖÊAµ½G£¬ÊÇʲôÒâ˼£¿ÐèÒª·Ö±ð¶¨Î»ºÍ¿ØÖÆÂð£¿Ð»Ð»£¡ |
» ²ÂÄãϲ»¶
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ12È˻ظ´
µ÷¼ÁÇóÖú£¨ÉúÎïÓëÒ½Ò©£©
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¼ª´ó»¯Ñ§327Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸ÉúÎïÓëÒ½Ò©£¬296·Ö£¬Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
³õÊÔ301£¬´úÂë085701»·¾³¹¤³Ì£¬±¾Ë¶Ò»Ö£¬ËÄÁù¼¶Òѹý£¬ÓжþÇøÒ»×÷£¬¹²·¢±í5ƪÂÛÎÄ
ÒѾÓÐ8È˻ظ´
327¿¼Ñе÷¼ÁÍÆ¼ö
ÒѾÓÐ6È˻ظ´
328Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
»¯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ16È˻ظ´

jianxiao88
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 25 (СѧÉú)
- ½ð±Ò: 4823.9
- É¢½ð: 20
- ºì»¨: 1
- Ìû×Ó: 832
- ÔÚÏß: 38.4Сʱ
- ³æºÅ: 1089124
- ×¢²á: 2010-09-04
- ÐÔ±ð: GG
- רҵ: É«Æ×·ÖÎö
|
ûÓÐÕâ¶Î»° µ¥´¿µÄÔÚËùÓвâÊÔÏîĿ֮ºó£¨´æ´¢Ìõ¼þÊÇ×îºóÒ»Ï ÁíÆðÒ»ÐУ¬Ð´µÄImpurities ºóÃæ±ãÂÞÁÐÁËÔÓÖÊAµ½GµÄÃû³ÆºÍ½á¹¹ Ö®ºóÕâ¸ö²úÆ·µÄÏà¹ØÄÚÈݾͽáÊøÁË Ò²¾ÍÊÇ˵ÕâЩÔÓÖÊû±ØÒª×¨ÃÅÂò»ØÀ´ÒÀ´Î¶¨Î»£¬¿´¿´ÑùÆ·ÀïÊÇ·ñÓÐÕâЩÔÓÖÊ£¨ÒòΪÔÓÖʵijɱ¾È·ÊµÌ«¸ßÁË£©£»Ö»ÐèÒªµ±ÔÓÖÊ´óÓÚ0.1%ʱ£¬²ÉȡһЩ±ðµÄÀàËÆMSµÈÊÖ¶ÎÀ´¼ø¶¨Æä½á¹¹¾ÍOKÁË £¬ÊÇÕâ¸öÒâ˼°É£¿£¨µÚÒ»´Î×öÅ·ÖÞÒ©µäµÄ·½·¨£¬ºÜ¶à¶«Î÷²»Çå³þ£© |

6Â¥2017-08-24 11:20:46
Ã÷ÔµÄÒ¹
ľ³æÖ®Íõ (ÎÄ̳¾«Ó¢)
Ô¶ù£¬Ô¶ù£¬Ô¶ù¡£¡£¡£ÄãÔÚÄÄ
- Ó¦Öú: 45 (СѧÉú)
- ½ð±Ò: 65027.7
- É¢½ð: 10015
- ºì»¨: 153
- Ìû×Ó: 10095
- ÔÚÏß: 561Сʱ
- ³æºÅ: 6906871
- ×¢²á: 2017-07-05
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
| Äã¿´Ï·½·¨µÄ¼ÆËã·½·¨£¬¿´¿´ÊÇÔõô¼ÆËãµÄ¡£Ò»°ãÓÃÍâ±ê·¨¼ÆËã¡£ÁÐÁËÄÇô¶àÔÓÖÊ£¬Ö»ÊǸæËßÄãÓÐÕâЩÒÑÖªÔÓÖÊ¡£ |

2Â¥2017-08-23 12:52:34
zhgjsyzhyang
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 50 (СѧÉú)
- ½ð±Ò: 474.4
- ºì»¨: 3
- Ìû×Ó: 235
- ÔÚÏß: 340.4Сʱ
- ³æºÅ: 1174226
- ×¢²á: 2010-12-21
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
Äã¿´¿´ÓÐûÓС°Other detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other/unspecified impurities and/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance.¡±ÀàËÆµÄ»°£¬ °´ÕÕĿǰµÄÒªÇóÀ´¿´£¬ÈçÓиßÓÚ0.1%ÔÓÖÊ£¬»¹ÊÇÐèÒªµ¥¶À¶¨ÐÔ¡¢¶¨Á¿µÄ |
3Â¥2017-08-23 17:29:21
yjjc2012
¾èÖú¹ó±ö (ÖøÃûдÊÖ)
- Ó¦Öú: 198 (¸ßÖÐÉú)
- ½ð±Ò: 3628
- É¢½ð: 85
- ºì»¨: 50
- Ìû×Ó: 2481
- ÔÚÏß: 433.7Сʱ
- ³æºÅ: 2276674
- ×¢²á: 2013-02-07
- רҵ: »ù´¡ÎïÀíѧ
|
Ö»ÓÐspecified impurity²Å±ØÐë¿ØÖÆ¡£ºóÃæÁгöµÄÄÇЩÔÓÖÊÊÇunspecified,²»³¬¹ý0.10%µÄ»°²»Óüø¶¨£¬²»³¬¹ý0.05%µÄ»°²»Óñ¨¸æ ·¢×ÔСľ³æAndroid¿Í»§¶Ë |
4Â¥2017-08-23 22:15:25














»Ø¸´´ËÂ¥
10